A previous study demonstrated that breast cancers with lymph node metastasis were more likely to be ECM1-positive (10/13, 76.9%) than those without metastasis (3/9, 33.3%) [10]. The gene discussed is ECM1; the disease is metastatic malignant neoplasm in the lymph nodes.